Fidelity International’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,467
| Closed | -$331K | – | 915 |
|
|
2024
Q3 | $331K | Buy |
11,467
+380
| +3% | +$11K | ﹤0.01% | 810 |
|
|
2024
Q2 | $425K | Buy |
11,087
+4,979
| +82% | +$191K | ﹤0.01% | 766 |
|
|
2024
Q1 | $359K | Buy |
6,108
+431
| +8% | +$25.3K | ﹤0.01% | 777 |
|
|
2023
Q4 | $340K | Buy |
+5,677
| New | +$340K | ﹤0.01% | 747 |
|
|
2021
Q3 | – | Sell |
-309,031
| Closed | -$19.5M | – | 824 |
|
|
2021
Q2 | $19.5M | Buy |
309,031
+1,456
| +0.5% | +$92K | 0.02% | 457 |
|
|
2021
Q1 | $13.2M | Sell |
307,575
-11,579
| -4% | -$497K | 0.02% | 486 |
|
|
2020
Q4 | $18.3M | Buy |
319,154
+189,835
| +147% | +$10.9M | 0.02% | 417 |
|
|
2020
Q3 | $3.9M | Sell |
129,319
-850,397
| -87% | -$25.7M | ﹤0.01% | 553 |
|
|
2020
Q2 | $32M | Sell |
979,716
-124,633
| -11% | -$4.07M | 0.04% | 326 |
|
|
2020
Q1 | $29.6M | Sell |
1,104,349
-289,936
| -21% | -$7.77M | 0.05% | 300 |
|
|
2019
Q4 | $42.7M | Buy |
1,394,285
+297,083
| +27% | +$9.1M | 0.06% | 280 |
|
|
2019
Q3 | $26.4M | Buy |
+1,097,202
| New | +$26.4M | 0.04% | 333 |
|